TechNavio's analysts forecast the
Regenerative Medicine market in the US to grow at a CAGR of 15.83 percent over
the period 2012-2016. One of the key factors contributing to this market growth
is the increasing number of degenerative diseases. The Regenerative Medicine
market in the US has also been witnessing an increasing number of mergers and
acquisitions. However, stringent regulatory approval processes could pose a
challenge to the growth of this market.
To
Read the Complete Report with TOC Visit:
http://www.marketresearchreports.biz/analysis-details/regenerative-medicine-market-in-the-us-2012-2016
TechNavio's report, the Regenerative
Medicine Market in the US 2012-2016, has been prepared based on an in-depth
market analysis with inputs from industry experts. The report covers the market
landscape and its growth prospects in the coming years in the US. The report
also includes a discussion of the key vendors operating in this market.
The key vendors dominating this
space include Baxter International Inc., Medtronic Inc., Stryker Corp., and
Zimmer Holdings Inc.
The other vendors mentioned in the
report are Advanced Cell Technology Inc., Athersys Inc., Arteriocyte Inc., Cytori
Therapeutics Inc., CryoLife, Inc., Genzyme Corp., Geron Corp., Integra Life
Sciences Holdings Corp., InVivo Therapeutics, Kensey Nash Corp., Kinetic
Concepts Inc., NeoStem Inc., Osiris Therapeutics Inc., Osteotech Inc., and RTI
Biologics Inc.
Key questions answered in this
report:
- What will the market size be in 2016 and what will be the growth rate?
- What are key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by key vendors?
- What are the strengths and weaknesses of each of these key vendors?
Contact
M/s Sheela
90 Sate Street, Suite
700
Albany, NY 12207
USA – Canada Toll
Free: 866-997-4948
No comments:
Post a Comment